These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35934781)

  • 1. Paradoxical Long-Term Impact Between Serum Apolipoprotein E and High-Density Lipoprotein Cholesterol in Patients Undergoing Percutaneous Coronary Intervention.
    Fukase T; Dohi T; Nishio R; Takeuchi M; Takahashi N; Chikata Y; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
    J Atheroscler Thromb; 2023 Jun; 30(6):611-623. PubMed ID: 35934781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study.
    Ren X; Wang X
    Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum apolipoprotein E levels predict residual cardiovascular risk in patients with chronic coronary syndrome undergoing first percutaneous coronary intervention and on-statin treatment.
    Fukase T; Dohi T; Chikata Y; Takahashi N; Endo H; Doi S; Nishiyama H; Kato Y; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Daida H; Minamino T
    Atherosclerosis; 2021 Sep; 333():9-15. PubMed ID: 34418683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention).
    Chen L; Zhao Y; Wang Z; Wang Y; Bo X; Jiang X; Hao C; Ju C; Qu Y; Dong H
    BMC Cardiovasc Disord; 2023 Jul; 23(1):357. PubMed ID: 37461001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between plasma HDL-C levels and coronary artery severity and impact on outcomes of patients underwent percutaneous coronary intervention].
    Song Y; Jiang L; Chen Y; Song L; Zhang Y; Gao LJ; Xu LJ; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Feb; 48(2):123-129. PubMed ID: 32135612
    [No Abstract]   [Full Text] [Related]  

  • 7. [The impact of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year outcome in patients with premature coronary heart disease: results of a prospective, multicenter, observational cohort study].
    Xu JJ; Chen J; Liu YX; Song Y; Jiang L; Yan SD; Guo WY; Yao Y; Jia SD; Yuan DS; Wang PZ; Li JX; Zhao XY; Liu ZY; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):702-708. PubMed ID: 37460423
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined impacts of low apolipoprotein A-I levels and reduced renal function on long-term prognosis in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Fukase T; Dohi T; Nishio R; Takeuchi M; Takahashi N; Chikata Y; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
    Clin Chim Acta; 2022 Nov; 536():180-190. PubMed ID: 36202225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of high-density lipoprotein levels at hospital admission on the outcome of patients with acute ST-segment elevation myocardial infarction].
    Sun YJ; Jiang DM; Zhang B; Gao Y; Li YZ; Yu HJ; Qi GX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):332-6. PubMed ID: 22613390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
    Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
    Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study.
    Liu J; Oorloff MD; Nadella A; Guo P; Ye M; Wang X; Zhao H
    Lipids Health Dis; 2024 Oct; 23(1):324. PubMed ID: 39354522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-HDL cholesterol is an independent predictor of long-term cardiovascular events in patients with dyslipidemia after renal transplantation.
    Karabulut U; Çakır Ü
    Int J Clin Pract; 2021 Sep; 75(9):e14465. PubMed ID: 34107128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
    Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
    Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting blood glucose to HDL-C ratio as a novel predictor of clinical outcomes in non-diabetic patients after PCI.
    Guo QQ; Zheng YY; Tang JN; Wu TT; Yang XM; Zhang ZL; Zhang JC; Yang Y; Hou XG; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Dai XY; Zheng RJ; Xie X; Zhang JY
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33140818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-based association between high-density lipoprotein cholesterol and adverse outcomes after coronary artery bypass grafting.
    Montazeri Namin S; Moradi A; Tavolinejad H; Vasheghani-Farahani A; Jalali A; Pashang M; Sadeghian S; Bagheri J; Mansourian S; Mehrani M; Hosseini K; Rashedi S; Tajdini M
    BMC Cardiovasc Disord; 2024 Apr; 24(1):194. PubMed ID: 38580951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris.
    Hirayama K; Ota T; Harada K; Shibata Y; Tatami Y; Harata S; Kawashima K; Kunimura A; Shimbo Y; Takayama Y; Kawamiya T; Yamamoto D; Osugi N; Suzuki S; Ishii H; Murohara T
    Clin Ther; 2017 Feb; 39(2):279-287. PubMed ID: 28034517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between paradoxical decrease in high-density lipoprotein cholesterol levels after statin therapy and adverse cardiovascular events in patients with acute myocardial infarction.
    Ota T; Ishii H; Suzuki S; Tanaka A; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
    Am J Cardiol; 2015 Feb; 115(4):411-6. PubMed ID: 25555656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk: A community-based cohort study.
    Qi Y; Liu J; Wang W; Wang M; Zhao F; Sun J; Liu J; Zhao D
    J Clin Lipidol; 2018; 12(1):89-98.e2. PubMed ID: 29217413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.